Persistent High Burden of Advanced HIV Disease Among Patients Seeking Care in South Africa's National HIV Program: Data From a Nationwide Laboratory Cohort
- PMID: 29514238
- PMCID: PMC5850436
- DOI: 10.1093/cid/ciy045
Persistent High Burden of Advanced HIV Disease Among Patients Seeking Care in South Africa's National HIV Program: Data From a Nationwide Laboratory Cohort
Abstract
Background: The South African national HIV program has increased antiretroviral therapy (ART) coverage over the last decade, supported by policy changes allowing for earlier ART initiation. However, many patients still enter care with advanced (<200 cells/μL) and very advanced (<100 cells/μL) HIV disease. We assessed disease progression at entry to care using nationwide laboratory data.
Methods: We constructed a national HIV cohort using laboratory records containing HIV RNA loads and CD4 counts from 2004 to 2016 to determine entry into care. We estimated numbers and proportions of adults with the first CD4 count <100 cells/ μL or 100-199 cells/μL. We calculated relative risks of presenting with advanced disease associated with male sex.
Results: 8.04 million first CD4 results were identified. From 2005 to 2011, the proportion of patients entering into care with CD4 count <200 cells/μL declined from 46.8% to 35.6%. From 2011 onward, the proportion of patients entering ART with advanced HIV disease has remained relatively unchanged. In 2016, we estimated that of 654 868 patients entering care, 32.9% had advanced HIV disease, and 16.8% had very advanced HIV disease. Men were almost twice as likely as women (23.1% vs 12.6% ) to enter care with very advanced HIV disease.
Conclusions: The proportion of patients presenting with advanced HIV disease in South Africa remains consistently high despite ART scale-up, representing a large and avoidable burden of morbidity. Early HIV diagnosis, rapid linkage to ART and approaches to attract men into early ART initiation should be prioritized.
Figures



Similar articles
-
Adolescent HIV treatment in South Africa's national HIV programme: a retrospective cohort study.Lancet HIV. 2019 Nov;6(11):e760-e768. doi: 10.1016/S2352-3018(19)30234-6. Epub 2019 Oct 1. Lancet HIV. 2019. PMID: 31585836 Free PMC article.
-
CD4 count recovery and associated factors among individuals enrolled in the South African antiretroviral therapy programme: An analysis of national laboratory based data.PLoS One. 2019 May 31;14(5):e0217742. doi: 10.1371/journal.pone.0217742. eCollection 2019. PLoS One. 2019. PMID: 31150489 Free PMC article.
-
The Continuing Burden of Advanced HIV Disease Over 10 Years of Increasing Antiretroviral Therapy Coverage in South Africa.Clin Infect Dis. 2018 Mar 4;66(suppl_2):S118-S125. doi: 10.1093/cid/cix1140. Clin Infect Dis. 2018. PMID: 29514233 Free PMC article.
-
[National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].Enferm Infecc Microbiol Clin. 2011 Mar;29(3):209.e1-103. doi: 10.1016/j.eimc.2010.12.004. Enferm Infecc Microbiol Clin. 2011. PMID: 21388714 Spanish.
-
[Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].Enferm Infecc Microbiol Clin. 2012 Jun;30(6):e1-89. doi: 10.1016/j.eimc.2012.03.006. Epub 2012 May 23. Enferm Infecc Microbiol Clin. 2012. PMID: 22633764 Spanish.
Cited by
-
Persons living with HIV with advanced HIV disease: need for novel care models.J Int AIDS Soc. 2018 Dec;21(12):e25210. doi: 10.1002/jia2.25210. J Int AIDS Soc. 2018. PMID: 30549245 Free PMC article.
-
Rapid antiretroviral therapy initiation in patients with advanced HIV disease: 6-month outcomes of an observational cohort evaluation in Lesotho.PLoS One. 2023 Oct 11;18(10):e0292660. doi: 10.1371/journal.pone.0292660. eCollection 2023. PLoS One. 2023. PMID: 37819941 Free PMC article.
-
Lack of Atorvastatin Effect on Monocyte Gene Expression and Inflammatory Markers in HIV-1-infected ART-suppressed Individuals at Risk of non-AIDS Comorbidities.Pathog Immun. 2021 Aug 13;6(2):1-26. doi: 10.20411/pai.v6i2.461. eCollection 2021. Pathog Immun. 2021. PMID: 34447895 Free PMC article.
-
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.N Engl J Med. 2022 Mar 24;386(12):1109-1120. doi: 10.1056/NEJMoa2111904. N Engl J Med. 2022. PMID: 35320642 Free PMC article. Clinical Trial.
-
SEARCH Human Immunodeficiency Virus (HIV) Streamlined Treatment Intervention Reduces Mortality at a Population Level in Men With Low CD4 Counts.Clin Infect Dis. 2021 Oct 5;73(7):e1938-e1945. doi: 10.1093/cid/ciaa1782. Clin Infect Dis. 2021. PMID: 33783495 Free PMC article. Clinical Trial.
References
-
- Joint United Nations Programme on HIV/AIDS. UNAIDS data 2017. Geneva, Switzerland: UNAIDS, 2017. - PubMed
-
- South African AIDS Council. South Africa’s national strategic plan for HIV, TB and STIs 2017–2022. Pretoria, South Africa: SANAC, 2017.
-
- South Africa National Department of Health. National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults. Pretoria, South Africa: NDOH, 2014.
-
- South Africa National Department of Health. The South African antiretroviral treatment guidelines 2013. Pretoria, South Africa: NDOH, 2013.
-
- South Africa National Department of Health. Policy and guidelines for the implementation of the PMTCT programme. Pretoria, South Africa: NDOH, 2008.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials